Primary treatment of pelvic organ prolapse: pessary use versus prolapse surgery

Introduction and hypothesis The objective of this study was to compare the functional outcomes after pessary treatment and after prolapse surgery as primary treatments for pelvic organ prolapse (POP). Methods This was a prospective cohort study performed in a Dutch teaching hospital in women with sy...

Full description

Saved in:
Bibliographic Details
Published in:International Urogynecology Journal Vol. 29; no. 1; pp. 99 - 107
Main Authors: Coolen, Anne-Lotte W. M., Troost, Stephanie, Mol, Ben Willem J., Roovers, Jan- Paul W. R., Bongers, Marlies Y.
Format: Journal Article
Language:English
Published: London Springer London 01-01-2018
Springer Nature B.V
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Introduction and hypothesis The objective of this study was to compare the functional outcomes after pessary treatment and after prolapse surgery as primary treatments for pelvic organ prolapse (POP). Methods This was a prospective cohort study performed in a Dutch teaching hospital in women with symptomatic POP of stage II or higher requiring treatment. Patients were treated according to their preference with a pessary or prolapse surgery. The primary endpoint was disease-specific quality of life at 12 months follow-up according to the prolapse domain of the Urogenital Distress Inventory (UDI) questionnaire. Secondary outcomes included adverse events and additional interventions. To show a difference of ten points in the primary outcome, we needed to randomize 80 women (power 80%, α 0.05, taking 10% attrition into account). Results We included 113 women (74 in the pessary group, 39 in the surgery group). After 12 months, the median prolapse domain score was 0 (10th to 90th percentile 0–33) in the pessary group and 0 (10th to 90th percentile 0–0) in the surgery group ( p  < 0.01). Differences in other domain scores were not statistically significant. In the pessary group, 28% (21/74) of the women had a surgical intervention versus 3% (1/39) reoperations in the surgery group ( p  = 0.01). Conclusions In women with POP of stage II or higher undergoing surgery, prolapse symptoms were less severe than in those who were treated with a pessary, but 72% of women who were treated with a pessary did not opt for surgery. Trial registration number: Dutch trial register NTR2856.
AbstractList Introduction and hypothesis The objective of this study was to compare the functional outcomes after pessary treatment and after prolapse surgery as primary treatments for pelvic organ prolapse (POP). Methods This was a prospective cohort study performed in a Dutch teaching hospital in women with symptomatic POP of stage II or higher requiring treatment. Patients were treated according to their preference with a pessary or prolapse surgery. The primary endpoint was disease-specific quality of life at 12 months follow-up according to the prolapse domain of the Urogenital Distress Inventory (UDI) questionnaire. Secondary outcomes included adverse events and additional interventions. To show a difference of ten points in the primary outcome, we needed to randomize 80 women (power 80%, α 0.05, taking 10% attrition into account). Results We included 113 women (74 in the pessary group, 39 in the surgery group). After 12 months, the median prolapse domain score was 0 (10th to 90th percentile 0–33) in the pessary group and 0 (10th to 90th percentile 0–0) in the surgery group ( p  < 0.01). Differences in other domain scores were not statistically significant. In the pessary group, 28% (21/74) of the women had a surgical intervention versus 3% (1/39) reoperations in the surgery group ( p  = 0.01). Conclusions In women with POP of stage II or higher undergoing surgery, prolapse symptoms were less severe than in those who were treated with a pessary, but 72% of women who were treated with a pessary did not opt for surgery. Trial registration number: Dutch trial register NTR2856.
INTRODUCTION AND HYPOTHESISThe objective of this study was to compare the functional outcomes after pessary treatment and after prolapse surgery as primary treatments for pelvic organ prolapse (POP).METHODSThis was a prospective cohort study performed in a Dutch teaching hospital in women with symptomatic POP of stage II or higher requiring treatment. Patients were treated according to their preference with a pessary or prolapse surgery. The primary endpoint was disease-specific quality of life at 12 months follow-up according to the prolapse domain of the Urogenital Distress Inventory (UDI) questionnaire. Secondary outcomes included adverse events and additional interventions. To show a difference of ten points in the primary outcome, we needed to randomize 80 women (power 80%, α 0.05, taking 10% attrition into account).RESULTSWe included 113 women (74 in the pessary group, 39 in the surgery group). After 12 months, the median prolapse domain score was 0 (10th to 90th percentile 0-33) in the pessary group and 0 (10th to 90th percentile 0-0) in the surgery group (p < 0.01). Differences in other domain scores were not statistically significant. In the pessary group, 28% (21/74) of the women had a surgical intervention versus 3% (1/39) reoperations in the surgery group (p = 0.01).CONCLUSIONSIn women with POP of stage II or higher undergoing surgery, prolapse symptoms were less severe than in those who were treated with a pessary, but 72% of women who were treated with a pessary did not opt for surgery.TRIAL REGISTRATION NUMBERDutch trial register NTR2856.
Introduction and hypothesisThe objective of this study was to compare the functional outcomes after pessary treatment and after prolapse surgery as primary treatments for pelvic organ prolapse (POP).MethodsThis was a prospective cohort study performed in a Dutch teaching hospital in women with symptomatic POP of stage II or higher requiring treatment. Patients were treated according to their preference with a pessary or prolapse surgery. The primary endpoint was disease-specific quality of life at 12 months follow-up according to the prolapse domain of the Urogenital Distress Inventory (UDI) questionnaire. Secondary outcomes included adverse events and additional interventions. To show a difference of ten points in the primary outcome, we needed to randomize 80 women (power 80%, α 0.05, taking 10% attrition into account).ResultsWe included 113 women (74 in the pessary group, 39 in the surgery group). After 12 months, the median prolapse domain score was 0 (10th to 90th percentile 0–33) in the pessary group and 0 (10th to 90th percentile 0–0) in the surgery group (p < 0.01). Differences in other domain scores were not statistically significant. In the pessary group, 28% (21/74) of the women had a surgical intervention versus 3% (1/39) reoperations in the surgery group (p = 0.01).ConclusionsIn women with POP of stage II or higher undergoing surgery, prolapse symptoms were less severe than in those who were treated with a pessary, but 72% of women who were treated with a pessary did not opt for surgery.Trial registration number: Dutch trial register NTR2856.
The objective of this study was to compare the functional outcomes after pessary treatment and after prolapse surgery as primary treatments for pelvic organ prolapse (POP). This was a prospective cohort study performed in a Dutch teaching hospital in women with symptomatic POP of stage II or higher requiring treatment. Patients were treated according to their preference with a pessary or prolapse surgery. The primary endpoint was disease-specific quality of life at 12 months follow-up according to the prolapse domain of the Urogenital Distress Inventory (UDI) questionnaire. Secondary outcomes included adverse events and additional interventions. To show a difference of ten points in the primary outcome, we needed to randomize 80 women (power 80%, α 0.05, taking 10% attrition into account). We included 113 women (74 in the pessary group, 39 in the surgery group). After 12 months, the median prolapse domain score was 0 (10th to 90th percentile 0-33) in the pessary group and 0 (10th to 90th percentile 0-0) in the surgery group (p < 0.01). Differences in other domain scores were not statistically significant. In the pessary group, 28% (21/74) of the women had a surgical intervention versus 3% (1/39) reoperations in the surgery group (p = 0.01). In women with POP of stage II or higher undergoing surgery, prolapse symptoms were less severe than in those who were treated with a pessary, but 72% of women who were treated with a pessary did not opt for surgery. Dutch trial register NTR2856.
Author Troost, Stephanie
Bongers, Marlies Y.
Mol, Ben Willem J.
Coolen, Anne-Lotte W. M.
Roovers, Jan- Paul W. R.
Author_xml – sequence: 1
  givenname: Anne-Lotte W. M.
  orcidid: 0000-0002-0056-0804
  surname: Coolen
  fullname: Coolen, Anne-Lotte W. M.
  email: anne_lotte_coolen@hotmail.com
  organization: Department of Gynecology and Obstetics, Máxima Medical Centre
– sequence: 2
  givenname: Stephanie
  surname: Troost
  fullname: Troost, Stephanie
  organization: Department of Gynecology and Obstetics, Máxima Medical Centre
– sequence: 3
  givenname: Ben Willem J.
  surname: Mol
  fullname: Mol, Ben Willem J.
  organization: Department of Gynaecology and Obstetrics, The Robinson Research Institute, School of Paediatrics and Reproductive Health, University of Adelaide
– sequence: 4
  givenname: Jan- Paul W. R.
  surname: Roovers
  fullname: Roovers, Jan- Paul W. R.
  organization: Department of Gynaecology and Obstetrics, Academic Medical Centre Amsterdam
– sequence: 5
  givenname: Marlies Y.
  surname: Bongers
  fullname: Bongers, Marlies Y.
  organization: Department of Gynecology and Obstetics, Máxima Medical Centre, Department of Gynaecology and Obstetrics, Grow School of Oncology and Biological Diversity, Maastricht University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28600758$$D View this record in MEDLINE/PubMed
BookMark eNp1kU9r3DAQxUVJaDZpP0AvxdBLL25GkvXHPRRCaJNCIDm0Z6GVx1sHr-Vq7CX59tXidEkLOQ3o_eZpZt4pOxrigIy94_CJA5hzAuC1KIGbUkojyodXbMUrKUsJQh6xFdQyK5UWJ-yU6B4AKlDwmp0Iq3O_sit2e5e6rU-PxZTQT1scpiK2xYj9rgtFTBs_FGOKvR8JP-dnoj07ExY7TDTTQSxoThtMj2_Ycet7wrdP9Yz9_Pb1x-V1eXN79f3y4qYMSuqpFMryeq1lY9pmDbW2AnJBLb0PXIrG1K2RvlWhWaMWolbccosaGx-E4UHIM_Zl8R3n9RabkAdPvnfjso2LvnP_KkP3y23izimjqgogG3x8Mkjx94w0uW1HAfveDxhncrwGWwlra5XRD_-h93FOQ14vU7bSxi6GfKFCikQJ28MwHNw-LrfE5XJcbh-Xe8g9759vcej4m08GxAJQloZ84Gdfv-j6B4VLo9w
CitedBy_id crossref_primary_10_1002_14651858_CD004010_pub4
crossref_primary_10_1097_SPV_0000000000001279
crossref_primary_10_1177_17455057231181012
crossref_primary_10_3390_jcm9113773
crossref_primary_10_1097_GME_0000000000001751
crossref_primary_10_1007_s00192_020_04338_w
crossref_primary_10_1007_s00192_020_04314_4
crossref_primary_10_2147_IJWH_S406048
crossref_primary_10_4240_wjgs_v13_i9_1063
crossref_primary_10_1007_s00192_023_05627_w
crossref_primary_10_1097_GME_0000000000001939
crossref_primary_10_1007_s00192_021_04843_6
crossref_primary_10_2147_IJWH_S413670
crossref_primary_10_1016_j_gine_2020_04_002
crossref_primary_10_1177_2053369120937594
crossref_primary_10_3390_medicina60040547
crossref_primary_10_1097_GME_0000000000001633
crossref_primary_10_1016_j_cont_2024_101318
crossref_primary_10_1097_SPV_0000000000001293
crossref_primary_10_1007_s00404_023_07177_4
crossref_primary_10_1001_jama_2022_22385
crossref_primary_10_1007_s11884_018_0469_0
crossref_primary_10_1186_s12905_019_0749_7
crossref_primary_10_1002_nau_24477
crossref_primary_10_1111_luts_12411
crossref_primary_10_1016_j_gofs_2018_05_003
crossref_primary_10_1098_rsfs_2019_0014
crossref_primary_10_1080_15398285_2020_1810966
crossref_primary_10_1007_s00192_019_03919_8
crossref_primary_10_1016_j_ajog_2023_01_006
crossref_primary_10_3889_oamjms_2022_8804
crossref_primary_10_1002_nau_24458
crossref_primary_10_1007_s00404_019_05046_7
crossref_primary_10_1097_SPV_0000000000000731
crossref_primary_10_1007_s00192_021_04817_8
crossref_primary_10_1111_1471_0528_16950
crossref_primary_10_1097_GME_0000000000001849
crossref_primary_10_4111_icu_20210395
crossref_primary_10_1097_LGT_0000000000000629
Cites_doi 10.1097/AOG.0b013e3181d055d4
10.1002/nau.10038
10.1097/01.AOG.0000222903.38684.cc
10.1159/000336634
10.1007/s00192-011-1390-7
10.1016/j.ogc.2009.08.010
10.1111/j.1471-0528.2005.00568.x
10.1056/NEJMoa1111967
10.1111/j.1471-0528.2009.02380.x
10.1007/s00192-010-1340-9
10.1111/j.1471-0528.2004.00001.x
10.1016/j.ajog.2003.10.711
10.1007/s00192-004-1226-9
10.1016/S0002-9378(96)70243-0
10.1007/s00192-009-0902-1
10.1016/S0029-7844(97)00058-6
10.1016/j.ajog.2007.08.013
10.1016/j.fertnstert.2008.02.142
10.1007/s00192-015-2686-9
10.1007/s10350-007-9147-6
ContentType Journal Article
Copyright The Author(s) 2017
International Urogynecology Journal is a copyright of Springer, (2017). All Rights Reserved.
Copyright_xml – notice: The Author(s) 2017
– notice: International Urogynecology Journal is a copyright of Springer, (2017). All Rights Reserved.
DBID C6C
NPM
AAYXX
CITATION
3V.
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1007/s00192-017-3372-x
DatabaseName SpringerOpen (Open Access)
PubMed
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Databases
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Medical Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Pharma Collection
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
ProQuest One Academic Eastern Edition
PubMed
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1433-3023
EndPage 107
ExternalDocumentID 10_1007_s00192_017_3372_x
28600758
Genre Journal Article
GrantInformation_xml – fundername: Maastricht University
– fundername: ;
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
1SB
2.D
203
28-
29J
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5VS
67Z
6NX
7X7
88E
8AO
8FI
8FJ
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AABYN
AAFGU
AAHNG
AAIAL
AAJKR
AAKSU
AANXM
AANZL
AAPBV
AARHV
AARTL
AATNV
AATVU
AAUYE
AAWCG
AAYFA
AAYIU
AAYQN
AAYTO
ABBBX
ABBXA
ABDZT
ABECU
ABFGW
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKAS
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABPTK
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACBMV
ACBRV
ACBXY
ACBYP
ACGFS
ACHSB
ACHXU
ACIGE
ACIPQ
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACSNA
ACTTH
ACUDM
ACVWB
ACWMK
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADMDM
ADOXG
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEEQQ
AEFIE
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESKC
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFAFS
AFEXP
AFKRA
AFLOW
AFNRJ
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGBP
AGGDS
AGJBK
AGKHE
AGMZJ
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJRNO
AJZVZ
AKMHD
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BVXVI
C6C
CCPQU
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GRRUI
GXS
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
M1P
M4Y
MA-
N2Q
N9A
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
ROL
RPX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UNUBA
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
YLTOR
Z45
Z7U
Z7W
Z81
Z82
Z87
Z8O
Z8Q
Z8U
Z8V
Z91
ZMTXR
ZOVNA
~EX
AACDK
AAEOY
AAJBT
AASML
AAYZH
ABAKF
ACAOD
ACDTI
ACZOJ
AEFQL
AEMSY
AFBBN
AGQEE
AGRTI
AIGIU
AJOOF
ALIPV
H13
NPM
AAYXX
CITATION
7XB
8FK
K9.
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c536t-25819b63d7fdb096820b09e63aac132d79f73af5cdbe622951818e6edac271c23
IEDL.DBID AEJHL
ISSN 0937-3462
IngestDate Tue Sep 17 21:18:57 EDT 2024
Fri Oct 25 10:29:34 EDT 2024
Mon Nov 04 11:12:46 EST 2024
Thu Nov 21 23:35:12 EST 2024
Wed Oct 16 00:59:36 EDT 2024
Sat Dec 16 12:06:01 EST 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Pessary
Prolapse surgery
Pelvic organ prolapse
Language English
License Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c536t-25819b63d7fdb096820b09e63aac132d79f73af5cdbe622951818e6edac271c23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-0056-0804
OpenAccessLink http://link.springer.com/10.1007/s00192-017-3372-x
PMID 28600758
PQID 1984678400
PQPubID 326303
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5754400
proquest_miscellaneous_1908428895
proquest_journals_1984678400
crossref_primary_10_1007_s00192_017_3372_x
pubmed_primary_28600758
springer_journals_10_1007_s00192_017_3372_x
PublicationCentury 2000
PublicationDate 2018-01-01
PublicationDateYYYYMMDD 2018-01-01
PublicationDate_xml – month: 01
  year: 2018
  text: 2018-01-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
– name: Guildford
PublicationSubtitle Including Pelvic Floor Dysfunction
PublicationTitle International Urogynecology Journal
PublicationTitleAbbrev Int Urogynecol J
PublicationTitleAlternate Int Urogynecol J
PublicationYear 2018
Publisher Springer London
Springer Nature B.V
Publisher_xml – name: Springer London
– name: Springer Nature B.V
References Lone, Thakar, Sultan (CR14) 2015; 26
Kuhn, Bapst, Stadlmayr, Vits, Mueller (CR9) 2009; 5
Bump, Mattiasson, Bø, Brubaker, DeLancey, Klarskov (CR15) 1996; 175
Olsen, Smith, Bergstrom, Colling, Clark (CR2) 1997; 89
Broens-Oostveen, Mom, Lagro-Janssen (CR12) 2004; 148
Clemons, Aguilar, Tillinghast, Jackson, Myers (CR20) 2004; 190
Van der Vaart, de Leeuw, Roovers, Heintz (CR16) 2003; 22
Richter, Burgio, Brubaker, Nygaard, Ye, Weidner (CR3) 2010; 115
Digesu, Chaliha, Salvatore, Hutchings, Khullar (CR6) 2005; 112
Komesu, Rogers, Rode, Craig, Gallegos, Montoya, Swartz (CR8) 2007; 197
Atnip (CR4) 2009; 36
Abdool, Thakar, Sultan, Oliver (CR11) 2011; 22
Wei, Nygaard, Richter, Nager, Barber (CR19) 2012; 366
Thys, Roovers, Geomini, Bongers (CR5) 2012; 74
Bai, Yoon, Kwon, Shin, Kim, Park (CR21) 2005; 16
Roovers, van der Bom, van der Vaart (CR17) 2008; 51
Slieker-ten Hove, Pool-Goudzwaard, Eijkemans, Steegers-Theunissen, Burger, Vierhout (CR1) 2009; 20
Lamers, Broekman, Milani (CR10) 2011; 22
Roovers, van der Vaart, van der Bom, Heintz (CR18) 2004; 111
Fernando, Thakar, Sultan, Shah, Jones (CR7) 2006; 108
Sarma, Ying, Moore (CR13) 2009; 116
21161179 - Int Urogynecol J. 2011 Mar;22(3):273-8
22716974 - N Engl J Med. 2012 Jun 21;366(25):2358-67
21472447 - Int Urogynecol J. 2011 Jun;22(6):637-44
15958002 - BJOG. 2005 Jul;112(7):971-6
9083302 - Obstet Gynecol. 1997 Apr;89(4):501-6
20177294 - Obstet Gynecol. 2010 Mar;115(3):609-17
19906018 - BJOG. 2009 Dec;116(13):1715-21
8694033 - Am J Obstet Gynecol. 1996 Jul;175(1):10-7
18443878 - Dis Colon Rectum. 2008 Jul;51(7):1068-72; discussion 1072-3
18410935 - Fertil Steril. 2009 May;91(5):1914-8
14687052 - BJOG. 2004 Jan;111(1):50-6
16816061 - Obstet Gynecol. 2006 Jul;108(1):93-9
15326649 - Ned Tijdschr Geneeskd. 2004 Jul 17;148(29):1444-8
19932415 - Obstet Gynecol Clin North Am. 2009 Sep;36(3):541-63
18060953 - Am J Obstet Gynecol. 2007 Dec;197(6):620.e1-6
19444368 - Int Urogynecol J Pelvic Floor Dysfunct. 2009 Sep;20(9):1037-45
25862241 - Int Urogynecol J. 2015 Sep;26(9):1305-12
15578156 - Int Urogynecol J Pelvic Floor Dysfunct. 2005 May-Jun;16(3):182-6; discussion 186
12579625 - Neurourol Urodyn. 2003;22(2):97-104
15118635 - Am J Obstet Gynecol. 2004 Apr;190(4):1025-9
22759810 - Gynecol Obstet Invest. 2012;74(1):6-12
Z Abdool (3372_CR11) 2011; 22
SD Thys (3372_CR5) 2012; 74
JP Roovers (3372_CR17) 2008; 51
BH Lamers (3372_CR10) 2011; 22
A Kuhn (3372_CR9) 2009; 5
JP Roovers (3372_CR18) 2004; 111
AL Olsen (3372_CR2) 1997; 89
JL Clemons (3372_CR20) 2004; 190
HE Richter (3372_CR3) 2010; 115
RJ Fernando (3372_CR7) 2006; 108
RC Bump (3372_CR15) 1996; 175
SD Atnip (3372_CR4) 2009; 36
F Lone (3372_CR14) 2015; 26
SW Bai (3372_CR21) 2005; 16
MC Broens-Oostveen (3372_CR12) 2004; 148
CH Van der Vaart (3372_CR16) 2003; 22
GA Digesu (3372_CR6) 2005; 112
S Sarma (3372_CR13) 2009; 116
MC Slieker-ten Hove (3372_CR1) 2009; 20
JT Wei (3372_CR19) 2012; 366
YM Komesu (3372_CR8) 2007; 197
References_xml – volume: 115
  start-page: 609
  issue: 3
  year: 2010
  end-page: 617
  ident: CR3
  article-title: Continence pessary compared with behavioral therapy or combined therapy for stress incontinence: a randomized controlled trial
  publication-title: Obstet Gynecol
  doi: 10.1097/AOG.0b013e3181d055d4
  contributor:
    fullname: Weidner
– volume: 148
  start-page: 1444
  issue: 29
  year: 2004
  end-page: 1448
  ident: CR12
  article-title: Genital prolapse; treatment and course in four general practices
  publication-title: Ned Tijdschr Geneeskd
  contributor:
    fullname: Lagro-Janssen
– volume: 22
  start-page: 97
  issue: 2
  year: 2003
  end-page: 104
  ident: CR16
  article-title: Measuring health-related quality of life in women with urogenital dysfunction: the Urogenital Distress Inventory and Incontinence Impact Questionnaire revisited
  publication-title: Neurourol Urodyn
  doi: 10.1002/nau.10038
  contributor:
    fullname: Heintz
– volume: 108
  start-page: 93
  issue: 1
  year: 2006
  end-page: 99
  ident: CR7
  article-title: Effect of vaginal pessaries on symptoms associated with pelvic organ prolapse
  publication-title: Obstet Gynecol
  doi: 10.1097/01.AOG.0000222903.38684.cc
  contributor:
    fullname: Jones
– volume: 74
  start-page: 6
  year: 2012
  end-page: 12
  ident: CR5
  article-title: Do patients prefer a pessary or surgery as primary treatment for pelvic organ prolapse
  publication-title: Gynecol Obstet Invest
  doi: 10.1159/000336634
  contributor:
    fullname: Bongers
– volume: 22
  start-page: 637
  year: 2011
  end-page: 664
  ident: CR10
  article-title: Pessary treatment for pelvic organ prolapse and health-related quality of life: a review
  publication-title: Int Urogynecol J
  doi: 10.1007/s00192-011-1390-7
  contributor:
    fullname: Milani
– volume: 36
  start-page: 541
  issue: 3
  year: 2009
  end-page: 563
  ident: CR4
  article-title: Pessary use and management for pelvic organ prolapse
  publication-title: Obstet Gynecol Clin North Am
  doi: 10.1016/j.ogc.2009.08.010
  contributor:
    fullname: Atnip
– volume: 112
  start-page: 971
  year: 2005
  end-page: 976
  ident: CR6
  article-title: The relationship of vaginal prolapse severity to symptoms and quality of life
  publication-title: BJOG
  doi: 10.1111/j.1471-0528.2005.00568.x
  contributor:
    fullname: Khullar
– volume: 366
  start-page: 2358
  year: 2012
  end-page: 2367
  ident: CR19
  article-title: A midurethral sling to reduce incontinence after vaginal prolapse repair
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1111967
  contributor:
    fullname: Barber
– volume: 116
  start-page: 1715
  issue: 13
  year: 2009
  end-page: 1721
  ident: CR13
  article-title: Long-term vaginal ring pessary use: discontinuation rates and adverse events
  publication-title: BJOG
  doi: 10.1111/j.1471-0528.2009.02380.x
  contributor:
    fullname: Moore
– volume: 22
  start-page: 273
  year: 2011
  end-page: 278
  ident: CR11
  article-title: Prospective evaluation of outcome of vaginal pessaries versus surgery in women with symptomatic pelvic organ prolapse
  publication-title: Int Urogynecol J
  doi: 10.1007/s00192-010-1340-9
  contributor:
    fullname: Oliver
– volume: 111
  start-page: 50
  year: 2004
  end-page: 56
  ident: CR18
  article-title: A randomised controlled trial comparing abdominal and vaginal prolapse surgery: effects on urogenital function
  publication-title: Br J Obstet Gynaecol
  doi: 10.1111/j.1471-0528.2004.00001.x
  contributor:
    fullname: Heintz
– volume: 190
  start-page: 1025
  issue: 4
  year: 2004
  end-page: 1029
  ident: CR20
  article-title: Patient satisfaction and changes in prolapse and urinary symptoms in women who were fitted successfully with a pessary for pelvic organ prolapse
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/j.ajog.2003.10.711
  contributor:
    fullname: Myers
– volume: 16
  start-page: 182
  issue: 3
  year: 2005
  end-page: 186
  ident: CR21
  article-title: Survey of the characteristics and satisfaction degree of the patients using a pessary
  publication-title: Int Urogynecol J Pelvic Floor Dysfunct
  doi: 10.1007/s00192-004-1226-9
  contributor:
    fullname: Park
– volume: 175
  start-page: 10
  issue: 1
  year: 1996
  end-page: 17
  ident: CR15
  article-title: The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/S0002-9378(96)70243-0
  contributor:
    fullname: Klarskov
– volume: 20
  start-page: 1037
  year: 2009
  end-page: 1045
  ident: CR1
  article-title: The prevalence of pelvic organ prolapse symptoms and signs and their relation with bladder and bowel disorders in a general female population
  publication-title: Int Urogynecol J Pelvic Floor Dysfunct
  doi: 10.1007/s00192-009-0902-1
  contributor:
    fullname: Vierhout
– volume: 89
  start-page: 501
  issue: 4
  year: 1997
  end-page: 506
  ident: CR2
  article-title: Epidemiology of surgically managed pelvic organ and urinary incontinence
  publication-title: Obstet Gynecol
  doi: 10.1016/S0029-7844(97)00058-6
  contributor:
    fullname: Clark
– volume: 197
  start-page: 620.e1
  year: 2007
  end-page: 620.e6
  ident: CR8
  article-title: Pelvic floor symptom changes in pessary users
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/j.ajog.2007.08.013
  contributor:
    fullname: Swartz
– volume: 5
  start-page: 1914
  year: 2009
  end-page: 1918
  ident: CR9
  article-title: Sexual and organ function in patients with symptomatic prolapse: are pessaries helpful?
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2008.02.142
  contributor:
    fullname: Mueller
– volume: 26
  start-page: 1305
  year: 2015
  end-page: 1312
  ident: CR14
  article-title: One-year prospective comparison of vaginal pessaries and surgery for pelvic organ prolapse using the validated ICIQ-VS and ICIQ-UI (SF) questionnaires
  publication-title: Int Urogynecol J
  doi: 10.1007/s00192-015-2686-9
  contributor:
    fullname: Sultan
– volume: 51
  start-page: 1068
  issue: 7
  year: 2008
  end-page: 1072
  ident: CR17
  article-title: Hysterectomy does not cause constipation
  publication-title: Dis Colon Rectum
  doi: 10.1007/s10350-007-9147-6
  contributor:
    fullname: van der Vaart
– volume: 89
  start-page: 501
  issue: 4
  year: 1997
  ident: 3372_CR2
  publication-title: Obstet Gynecol
  doi: 10.1016/S0029-7844(97)00058-6
  contributor:
    fullname: AL Olsen
– volume: 20
  start-page: 1037
  year: 2009
  ident: 3372_CR1
  publication-title: Int Urogynecol J Pelvic Floor Dysfunct
  doi: 10.1007/s00192-009-0902-1
  contributor:
    fullname: MC Slieker-ten Hove
– volume: 116
  start-page: 1715
  issue: 13
  year: 2009
  ident: 3372_CR13
  publication-title: BJOG
  doi: 10.1111/j.1471-0528.2009.02380.x
  contributor:
    fullname: S Sarma
– volume: 190
  start-page: 1025
  issue: 4
  year: 2004
  ident: 3372_CR20
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/j.ajog.2003.10.711
  contributor:
    fullname: JL Clemons
– volume: 197
  start-page: 620.e1
  year: 2007
  ident: 3372_CR8
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/j.ajog.2007.08.013
  contributor:
    fullname: YM Komesu
– volume: 5
  start-page: 1914
  year: 2009
  ident: 3372_CR9
  publication-title: Fertil Steril
  doi: 10.1016/j.fertnstert.2008.02.142
  contributor:
    fullname: A Kuhn
– volume: 112
  start-page: 971
  year: 2005
  ident: 3372_CR6
  publication-title: BJOG
  doi: 10.1111/j.1471-0528.2005.00568.x
  contributor:
    fullname: GA Digesu
– volume: 111
  start-page: 50
  year: 2004
  ident: 3372_CR18
  publication-title: Br J Obstet Gynaecol
  doi: 10.1111/j.1471-0528.2004.00001.x
  contributor:
    fullname: JP Roovers
– volume: 108
  start-page: 93
  issue: 1
  year: 2006
  ident: 3372_CR7
  publication-title: Obstet Gynecol
  doi: 10.1097/01.AOG.0000222903.38684.cc
  contributor:
    fullname: RJ Fernando
– volume: 366
  start-page: 2358
  year: 2012
  ident: 3372_CR19
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1111967
  contributor:
    fullname: JT Wei
– volume: 115
  start-page: 609
  issue: 3
  year: 2010
  ident: 3372_CR3
  publication-title: Obstet Gynecol
  doi: 10.1097/AOG.0b013e3181d055d4
  contributor:
    fullname: HE Richter
– volume: 22
  start-page: 637
  year: 2011
  ident: 3372_CR10
  publication-title: Int Urogynecol J
  doi: 10.1007/s00192-011-1390-7
  contributor:
    fullname: BH Lamers
– volume: 74
  start-page: 6
  year: 2012
  ident: 3372_CR5
  publication-title: Gynecol Obstet Invest
  doi: 10.1159/000336634
  contributor:
    fullname: SD Thys
– volume: 22
  start-page: 97
  issue: 2
  year: 2003
  ident: 3372_CR16
  publication-title: Neurourol Urodyn
  doi: 10.1002/nau.10038
  contributor:
    fullname: CH Van der Vaart
– volume: 175
  start-page: 10
  issue: 1
  year: 1996
  ident: 3372_CR15
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/S0002-9378(96)70243-0
  contributor:
    fullname: RC Bump
– volume: 51
  start-page: 1068
  issue: 7
  year: 2008
  ident: 3372_CR17
  publication-title: Dis Colon Rectum
  doi: 10.1007/s10350-007-9147-6
  contributor:
    fullname: JP Roovers
– volume: 148
  start-page: 1444
  issue: 29
  year: 2004
  ident: 3372_CR12
  publication-title: Ned Tijdschr Geneeskd
  contributor:
    fullname: MC Broens-Oostveen
– volume: 22
  start-page: 273
  year: 2011
  ident: 3372_CR11
  publication-title: Int Urogynecol J
  doi: 10.1007/s00192-010-1340-9
  contributor:
    fullname: Z Abdool
– volume: 16
  start-page: 182
  issue: 3
  year: 2005
  ident: 3372_CR21
  publication-title: Int Urogynecol J Pelvic Floor Dysfunct
  doi: 10.1007/s00192-004-1226-9
  contributor:
    fullname: SW Bai
– volume: 36
  start-page: 541
  issue: 3
  year: 2009
  ident: 3372_CR4
  publication-title: Obstet Gynecol Clin North Am
  doi: 10.1016/j.ogc.2009.08.010
  contributor:
    fullname: SD Atnip
– volume: 26
  start-page: 1305
  year: 2015
  ident: 3372_CR14
  publication-title: Int Urogynecol J
  doi: 10.1007/s00192-015-2686-9
  contributor:
    fullname: F Lone
SSID ssj0004050
ssj0001127576
Score 2.4410775
Snippet Introduction and hypothesis The objective of this study was to compare the functional outcomes after pessary treatment and after prolapse surgery as primary...
The objective of this study was to compare the functional outcomes after pessary treatment and after prolapse surgery as primary treatments for pelvic organ...
Introduction and hypothesisThe objective of this study was to compare the functional outcomes after pessary treatment and after prolapse surgery as primary...
INTRODUCTION AND HYPOTHESISThe objective of this study was to compare the functional outcomes after pessary treatment and after prolapse surgery as primary...
SourceID pubmedcentral
proquest
crossref
pubmed
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 99
SubjectTerms Gynecology
Health risk assessment
Medicine
Medicine & Public Health
Original
Original Article
Pelvic organ prolapse
Surgery
Urology
Title Primary treatment of pelvic organ prolapse: pessary use versus prolapse surgery
URI https://link.springer.com/article/10.1007/s00192-017-3372-x
https://www.ncbi.nlm.nih.gov/pubmed/28600758
https://www.proquest.com/docview/1984678400
https://search.proquest.com/docview/1908428895
https://pubmed.ncbi.nlm.nih.gov/PMC5754400
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB7BVkJcWl6FtAUZqSeQq6ydxE5vK9hqhehDKkjcItsZq4gqu2oaqT-_47xgWTjAKVI8TmyP7flmxp4BOMTc5yZPLJ8653lipeDW25w7iz4VpZvGGAxui0t19k1_nIcwOWI0XVQ_jgaPZLtRj3fdWjDCw6YqpRKccOMWiZ40mcDWbP5p8fmnZSXELA9CdrgdGbd5Wkl1p6pJJgbf5p8-ui6dNiDn5snJ39ynrVQ62fmf_jyB7R6Dslk3aZ7CA6yewaPT3sv-HM4vuhAUbDyFzpaerfCadhXWpoFi1OZrs6rxmF7XdaBtamThiEdTj4Ws7u5cv4CvJ_MvHxa8T7zAXSqzWy5Swgk2k6XypSUdh1ACPTCTxjjSXkuVeyWNT11pMQv5wAkmaMywNE6oqRNyFybVssJXwKg-qaDKEjAziUyUcd7EqHOtDRJSwwjeDQNerLrOFWMk5XaIChqiIgxRcRfBwcCSol9qdTHNA4QiPTWO4O1YTIskeD5Mhcsm0MSa9CydpxG87Dg4_k3oEKI_1RGoNd6OBCEA93pJ9f2qDcSdhuiB4b_vBxb_0qy_dWLvn6j34TFBNN0ZfQ5gcnvT4Gt4WJfNm37e3wNcuf4V
link.rule.ids 230,315,782,786,887,27934,27935,41074,42143,48345,48348,48358,49650,49653,49663,52154
linkProvider Springer Nature
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB7BVgIulGcJFDASJ5ClbJzEDreqdNmKtiCxSNwi2xmLSlV2RRqJn89MXrAUDnCKFI_jx8T2Nx77G4CXWITCFqmTc--DTJ1KpAuukN5hyJLKz2PkDbflJ332xbw9YpocNd6F6U67jy7JbqaeLrt1aETyrKqUTiQBxx0mO49nsHNwvHq3-Lm1wqTlvMqO1yPjLlAr2e6UNc2T0bn5p49uL09XMOfVo5O_-U-7ZWmx-18NugO3BxQqDvrf5i5cw_oe3Dgd_Oz34cPHnoRCTOfQxTqIDV7QvCK6QFCCKn1hNw2-oddNw7Jtg4IPebTNlCia_tb1A_i8OFodLuUQekH6TOWXMskIKbhcVTpUjqwcwgn0wFxZ68l-rXQRtLIh85XDnCOCE1AwmGNlfaLnPlEPYVava3wEgvKTEaodQTObqlRbH2yMpjDGImE1jODV2OPlpm9cOXEpd11UUheV3EXl9wj2R52Uw2BrynnBIIos1TiCF1MyDRP2fdga1y3LxIYsLVNkEez1KpxKSwyT9GcmAr2l3EmAKbi3U-rzrx0Vd8b8gVzu61HFv1Trb414_E_Sz-HmcnV6Up4cn71_ArcIsJl-C2gfZpffWnwK15uqfTYMgh95vgIL
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3di9QwEB90Dw5f_P6onhrBJyVct2mb1Bc5vF1WPc8DFXwrSTpB4egudgv--c70S9fTB_Gp0CRtM9Mkv8nM_ALwFItQ2CJ1cu59kKlTiXTBFdI7DFlS-XmMvOG2-qBPP5vjBdPkvBxzYbpo99El2ec0MEtTvT3cVOFwSnzrkInkGVYpnUgCkXsphxbOYO9o8WZ18nObhQnMecUdUyXj7tBWsuOpaZono6PzTw_dXaou4M-LYZS_-VK7JWp57b87dx2uDuhUHPW_0w24hPVN2H83-N9vwfuznpxCTPHpYh3EBs9pvhHdAVGCOnBuNw2-oNtNw3XbBgUHf7TNVCiaPhv7NnxaLj6-WsnhSAbpM5VvZZIRgnC5qnSoHFk_hB_ogrmy1pNdW-kiaGVD5iuHOZ8UTgDCYI6V9Yme-0TdgVm9rvEeCGpPxql2BNlsqlJtfbAxmsIYi4ThMIJno_TLTd-5cuJY7kRUkohKFlH5PYKDUT_lMAibcl4wuCILNo7gyVRMw4d9IrbGdct1YkMWmCmyCO726pzelhgm789MBHpH0VMFpubeLam_fukoujPmFeT3Ph_V_ctn_a0T9_-p9mPYPztelievT98-gCuE40y_M3QAs-23Fh_C5aZqHw3j4QfjwArX
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Primary+treatment+of+pelvic+organ+prolapse%3A+pessary+use+versus+prolapse+surgery&rft.jtitle=International+Urogynecology+Journal&rft.au=Coolen%2C+Anne-Lotte+W.+M.&rft.au=Troost%2C+Stephanie&rft.au=Mol%2C+Ben+Willem+J.&rft.au=Roovers%2C+Jan-+Paul+W.+R.&rft.date=2018-01-01&rft.pub=Springer+London&rft.issn=0937-3462&rft.eissn=1433-3023&rft.volume=29&rft.issue=1&rft.spage=99&rft.epage=107&rft_id=info:doi/10.1007%2Fs00192-017-3372-x&rft.externalDocID=10_1007_s00192_017_3372_x
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0937-3462&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0937-3462&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0937-3462&client=summon